Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00809146 · ClinicalTrials.gov registry record · Phase 3
Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications
A Phase 3 study of Status Epilepticus, sponsored by Robert Silbergleit.
- Completed
- Registry status
- Phase 3
- Development phase
- 1,023
- Enrollment target
- 17
- Study locations
NCT00809146: Completed Phase 3 study of Status Epilepticus, sponsored by Robert Silbergleit.
NCT00809146 is a Phase 3 study of Status Epilepticus that has completed, run by Robert Silbergleit. The registered enrollment target is 1,023 participants, below the 2,731-participant average among 10 other Status Epilepticus trials with a reported enrollment target (63% lower). The trial reports 17 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00809146, a Phase 3 study of Status Epilepticus, has completed, sponsored by Robert Silbergleit.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 1,023 participants
- Enrollment target
- 17
- Study locations
Study Summary
The goal of this non-inferiority trial is to determine which type of routine care is the best for paramedics to stop someone from seizing.
Primary Outcome
The primary outcome was termination of seizures before arrival in the emergency department (ED) without the need for the paramedics to provide rescue therapy. Subjects did not reach the primary outcome if they were having seizures on arrival in the emergency department or if they received rescue medication before arrival. Termination of seizures on arrival was determined according to the clinical judgment of the attending emergency physician and was based on examination of the subjects, their cl
Conditions Studied
Interventions
- DRUG Intramuscular route of active treatment
- DRUG Intravenous route of active treatment
Study Locations (17)
California
- Stanford University - Palo Alto
- University of California-San Francisco - San Francisco
Michigan
- Henry Ford Health System - Detroit
- Wayne State University - Detroit
Pennsylvania
- University of Pennsylvania/York - Philadelphia
- Temple University-Main Line - Philadelphia
Arizona
- University of Arizona - Tucson
Georgia
- Emory University - Atlanta
Kentucky
- University of Kentucky - Lexington
Maryland
- University of Maryland - Baltimore
Minnesota
- University of Minnesota - Minneapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,023 participants |
| Start Date | 2009-06 |
| Est. Completion | 2011-01 |
| Phase | Phase 3 |
What the finished NCT00809146 record still lists
NCT00809146 is an interventional study that assigns participants to a tested intervention. Its 1,023 participants enrollment target places it among the larger protocols in the corpus, below the 2,731-participant average among 10 other Status Epilepticus trials with a reported enrollment target (63% lower).
The record links to 1 condition, with Status Epilepticus appearing as the primary indexed condition, and to 2 interventions - of which Intramuscular route of active treatment is the first listed.
NCT00809146 lists 17 locations in 14 states (California, Michigan, Pennsylvania).
Frequently Asked Questions
What is clinical trial NCT00809146 about?
NCT00809146 is a clinical study titled "Paramedic Treatment of Prolonged Seizures by Intramuscular Versus Intravenous Anticonvulsant Medications". The goal of this non-inferiority trial is to determine which type of routine care is the best for paramedics to stop someone from seizing.
What is the current status of trial NCT00809146?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 1,023 participants. The study started on 2009-06. Estimated completion is 2011-01.
What conditions does trial NCT00809146 study?
This clinical trial studies the following conditions: Status Epilepticus.
What interventions are being tested in trial NCT00809146?
The interventions under investigation include: Intramuscular route of active treatment (DRUG), Intravenous route of active treatment (DRUG).
Who is sponsoring clinical trial NCT00809146?
This trial is sponsored by Robert Silbergleit, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00809146 being conducted?
This trial has 17 study locations across Arizona, California, Georgia, Kentucky, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Status Epilepticus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00809146's enrollment target sits among peer trials
1,023 3rd of 10 higher than 8 of 10 other Status Epilepticus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Status Epilepticus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketamine add-on Therapy for Established Status Epilepticus Treatment Trial (KESETT)
RECRUITING · Phase 3
-
Simulation Trial of Telemedical Support for Paramedics
RECRUITING · NA
-
Improving Status Epilepticus Treatment Times
RECRUITING · NA
-
PeRampanel fOr Status ePilEpticus pRophylaxis Post-cardiac Arrest
RECRUITING · Phase 2
-
Rapid-Response EEG in Children With Suspected Status Epilepticus
RECRUITING
-
Improving Outcomes for Patients With Life-Threatening Neurologic Illness
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07216703 · 1,023 participants · Phase 3
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
- NCT06888011 · 1,024 participants · NA
iAmHealthy Clinical Practice Guideline (CPG)
- NCT02200276 · 1,025 participants · NA
Influenza Immunization in Adults Over Age 75
- NCT02296450 · 1,025 participants
Quality of Life (QoL) Assessment in Cancer Patients and Survivors With Dermatologic Conditions Using Dermatologic QoL Instruments
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia